Find information on thousands of medical conditions and prescription drugs.

Hyperkalemia

Hyperkalemia (hyper is high, kalium is the Latin name for potassium) is an elevated blood level (above 5.0 mmol/L) of the electrolyte potassium. Extreme degrees of hyperkalemia are considered a medical emergency due to the risk of potentially fatal arrhythmias. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Signs and symptoms

Symptoms are fairly nonspecific, and generally include malaise and muscle weakness; mild breathlessness may indicate metabolic acidosis, one of the settings in which hyperkalemia may occur. Often, however, the problem is detected during screening blood tests for a medical disorder, or it only comes to medical attention after complications have developed, such as cardiac arrhythmia or sudden death.

During the medical history taking, a doctor will dwell on kidney disease and medication use (see below), as these are the main causes. The combination of abdominal pain, hypoglycemia and hyperpigmentation, often in the context of a history of other autoimmune disorders, may be signs of Addison's disease, itself a medical emergency.

Diagnosis

In order to gather enough information for diagnosis, the measurement of potassium needs to be repeated, as the elevation can be due to hemolysis of the material in the first sample. Generally, blood tests for renal function (creatinine, blood urea nitrogen), glucose and occasionally creatine kinase and cortisol will be performed. Calculating the trans-tubular potassium gradient can sometimes help in distinguishing the cause of the hyperkalemia.

Electrocardiography (ECG) is generally done early to identify any influences on the heart. High, tent-shaped T-waves, a small P wave and a wide QRS complex (that becomes sinusoidal) all identify the influence of excess potassium on the heart. This finding alone is an important reason for treatment, as it may forewarn ventricular fibrillation.

Often arterial blood gas measurements and renal ultrasound will be performed.

Differential diagnosis

Causes include:

Ineffective elimination from the body

  • Renal failure
  • Medication. Medication that can cause hyperkalemia (most are antihypertensives):
    • ACE inhibitors
    • Potassium-sparing diuretics (e.g. amiloride and spironolactone)
    • Angiotensin receptor blockers
    • Succinylcholine (also known as suxamethonium, a paralytic used in anesthesia)
  • Metabolic acidosis
  • Mineralocorticoid deficiency or resistance (many types)
    • Addison's disease
    • Aldosterone defiency
    • Congenital adrenal hyperplasia
  • Liddle syndrome, pseudohypoaldosteronism, other defects of renal tubular K excretion

Excessive release from cells

  • Rhabdomyolysis, burns or any cause of rapid tissue necrosis, including tumor lysis syndrome
  • Massive blood transfusion or massive hemolysis
  • Insulin deficiency

Excessive intake

  • Intoxication (potassium-containing dietary supplements or salt replacement)

Read more at Wikipedia.org


[List your site here Free!]


Hyperkalemia and renal dysfunction in congestive heart failure patients with concomitant use of spironolactone and furosemide
From CHEST, 10/1/05 by Nobuyuki Anzai

PURPOSE: This study aimed to identify predictors of hyperkalemia and renal impairment in congestive heart failure (CHF) patients taking spironolactone and furosemide.

METHODS: Ninety (90) consecutive patients with CHF, 46M/44F, mean age 73.8 (range 56.4-91.2 yrs) were studied. We started 26 patients while 20 patients were already taking spironolactone and furosemide when the study started. We measured blood electrolytes every two months. The study started from April 2003 and lasted two years. Mean observation duration was 489 days for 124 patient years with a mean 19 visits and a mean 25 days between visits.

RESULTS: Baseline characteristics: Mean (SD) left ventricular ejection fraction (LVEF): 39.5% (15.1); mean (SD) creatinine concentration(rag/ dl): 0.91 (0.25); mean serum potassium (mEq/dl): 4.3 (0.4); mean (SD) dosage (mg/day): spironolactone: 14.9 (7.3), furosemide: 30.3 (14.1); patients needing angiotensin converting enzymes (ACE) inhibitors or angiotensin receptor blockers (ARB): n = 50 (50%), [beta] blockers: 48 (53%); mean peak creatinine concentration: 1.07 (SD 0.34) mg/dl; mean peak potassium: 5.0 (SD 0.5) mEq/dl. A total of 45 (50%) had creatinine > 1.04 mEq/dl, 16 (18%) > 1.30, 9 (10%) > 1.50. Relative to baseline, 24 (27%) patients had creatine increase by 20%, 15 (17%) by 30%, 8 (9%) by 50%, 2 (2%) by 100%. A total of 39 (43%) patients had potassium > 5.0 mEq/dl, 9 (10%) >5.5, 2 (2%) > 6.0. Patients taking spironolactone and furosemide before study started did not differ significantly from patients we started in terms of hyperkalemia (potassium >5.5) (11.5% vs. 15.2%, p = 0.54) and azotemia (creatinine > 1.30) (15.3% vs. 14.1%, p = 0.82). We logistically regressed (30% increase in serum creatinine concentrations) with age, sex, use of ACE inihihitors, ARBs, [beta] blockers, and dosage of spironolactone and furosemide. Age (odds ratio 1.24 (95% confidence index interval 1.01-2.54) for each ten years)) was an independent risk factor for azotemia. For hyperkalemia (potassium > 5.5) we added to the model baseline creatinine concentrations and found that age (1.03(0.84-2.86)) was a predictive factor.

CONCLUSION: Age was a predictor of hyperkalemia and azotemia for patients taking spironolactone and furosemide with moderately decreased LVEF.

CLINICAL IMPLICATIONS: Caution should be taken while dose adjustment and continuous monitoring may be needed in elderly patients.

DISCLOSURE: Nobuyuki Anzai, None.

Nobuyuki Anzai MD * Hiroko Anzai MD Rieko Mitobe MD Makiko Anzai MD Sadako Furuya MD Anzai Furuya Clinic, Oyama, Japan

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Hyperkalemia
Home Contact Resources Exchange Links ebay